A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer.

Linking the molecular aberrations of cancer to drug responses could guide treatment choice and identify new therapeutic applications. However, there has been no systematic approach for analyzing gene-drug interactions in human cells. Here we establish a multiplexed assay to study the cellular fitnes...

Full description

Bibliographic Details
Main Authors: Muellner, M, Uras, I, Gapp, B, Kerzendorfer, C, Smida, M, Lechtermann, H, Craig-Mueller, N, Colinge, J, Duernberger, G, Nijman, S
Format: Journal article
Language:English
Published: 2011